Safety, reactogenicity and immunogenicity of a novel pneumococcal protein-based vaccine in adults: A phase I/II randomized clinical study-Reference-Cited by-同舟云学术

Safety, reactogenicity and immunogenicity of a novel pneumococcal protein-based vaccine in adults: A phase I/II randomized clinical study

Published:2014-11 Issue:50 Volume:32 Page:6838-6846
ISSN:0264-410X
Container-title:Vaccine
language:en
Short-container-title:Vaccine

Author:

Leroux-Roels Geert,Maes Cathy,De Boever Fien,Traskine Magali,Rüggeberg Jens U.,Borys Dorota^ORCID

Publisher

Elsevier BV

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,General Veterinary,General Immunology and Microbiology,Molecular Medicine

Reference34 articles.

1. Streptococcus pneumoniae: epidemiology and risk factors, evolution of antimicrobial resistance, and impact of vaccines;Lynch;Curr Opin Pulm Med,2010

2. Burden of disease caused by Streptococcus pneumoniae in children younger than 5 years: global estimates;O’Brien;Lancet,2009

3. Decline in pneumonia admissions after routine childhood immunisation with pneumococcal conjugate vaccine in the USA: a time-series analysis;Grijalva;Lancet,2007

4. Invasive pneumococcal disease after implementation of a reduced three-dose pneumococcal conjugate vaccine program: a pediatric tertiary care center experience;Crisinel;Eur J Pediatr,2010

5. Sustained reductions in invasive pneumococcal disease in the era of conjugate vaccine;Pilishvili;J Infect Dis,2010

Cited by 57 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Preliminary Evaluation of the Safety and Immunogenicity of a Novel Protein-Based Pneumococcal Vaccine in Healthy Adults Aged 18–49: A Phase Ia Randomized, Double Blind, Placebo-Controlled Clinical Study;Vaccines;2024-07-23

2. Bacterial Vaccinations in Patients with Chronic Obstructive Pulmonary Disease;Vaccines;2024-02-18

3. Otitis media: recent advances in otitis media vaccine development and model systems;Frontiers in Microbiology;2024-01-24

4. Peptide linker increased the stability of pneumococcal fusion protein vaccine candidate;Frontiers in Bioengineering and Biotechnology;2023-01-26

5. Pneumococcal Conjugate Vaccine and Pneumococcal Common Protein Vaccines;Plotkin's Vaccines;2023